Evidence map›Paper›PMID 42355861›Full record

ArticleJournal of clinical medicine2026

AIF, CK5/6, and CK20 in Bladder Urothelial Carcinoma: A Cross-Sectional Immunohistochemical Study of Grade and Stage Associations.

Pavel Babal, Stefan Harsanyi, Sebastian Kern, Kristina Mikus Kuracinova, Lucia Krivosikova, Branislav Trebaticky, Stanislav Ziaran, Andrea Janegova, Pavol Janega

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pavel BabalInstitute of Pathological Anatomy, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia.ORCID 0000-0001-8170-1850
Stefan HarsanyiInstitute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia.ORCID 0000-0002-7889-4898
Sebastian KernInstitute of Pathological Anatomy, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia.
Kristina Mikus KuracinovaInstitute of Pathological Anatomy, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia.ORCID 0000-0002-1555-3981
Lucia KrivosikovaInstitute of Pathological Anatomy, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia.ORCID 0000-0002-4053-7326
Branislav TrebatickyDepartment of Urology, Academician Ladislav Dérer Hospital, University Hospital Bratislava, 833 05 Bratislava, Slovakia.
Stanislav ZiaranDepartment of Urology, Ružinov Hospital, Faculty of Medicine, Comenius University and University Hospital Bratislava, 826 06 Bratislava, Slovakia.
Andrea JanegovaInstitute of Pathological Anatomy, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia.
Pavol JanegaInstitute of Pathological Anatomy, Faculty of Medicine, Comenius University in Bratislava, 811 08 Bratislava, Slovakia.ORCID 0000-0003-0036-7286

Funding

EU NextGenerationEU through the Recovery and Resilience Plan for Slovakia 09I03-03-V03-00046
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

apoptosis-inducing factorbladder cancercytokeratin 20cytokeratin 5/6immunohistochemistry markersstratification

Identifiers

PMID42355861
PMCPMC13301358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.